-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OFIIQRPqGuwE9QZ2v1aWYlU1hiYQOFHB90mFCIsMlPPCTTkab1o3wRP8ULlb7Wcl S5NM/WysSDALqftHHhsung== 0000897101-97-001128.txt : 19971107 0000897101-97-001128.hdr.sgml : 19971107 ACCESSION NUMBER: 0000897101-97-001128 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19971104 ITEM INFORMATION: FILED AS OF DATE: 19971106 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: CELOX LABORATORIES INC CENTRAL INDEX KEY: 0000883720 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 333384240 STATE OF INCORPORATION: MN FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 000-19866 FILM NUMBER: 97708807 BUSINESS ADDRESS: STREET 1: 856 SOUTH FIFTH ST CITY: HOPKINS STATE: MN ZIP: 55343 BUSINESS PHONE: 6129332616 MAIL ADDRESS: STREET 1: 856 S FIFTH STREET CITY: HOPKINS STATE: MN ZIP: 55343 FORMER COMPANY: FORMER CONFORMED NAME: CELOX CORPORATION DATE OF NAME CHANGE: 19930328 8-K 1 U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report: November 4, 1997 Commission file number 0-19866 CELOX LABORATORIES, INC. ------------------------ (Exact name of small business issuer as specified in its charter) MINNESOTA 36-3384240 --------- ---------- (State or other jurisdiction (I.R.S. Employer of incorporation or organization) Identification Number) 1311 HELMO AVENUE, OAKDALE, MINNESOTA 55128 - ---------------------------------------- ----- (Address of principal executive offices) (Zip code) Issuers telephone number, including area code: (612) 730-1500 Item 5. Other Events-Resignations from the Board of Directors During the last week of October, 1997 the Chairman of the Board of Directors requested and received resignations from the Company's three outside directors. These resignations had been requested by the Chairman based upon the strategic focus of the Company and the need for expertise in the bio medical field. As a result, the Company does not have any outside directors. The Company intends to identify and interview qualified candidates for the open director positions as soon as practical. SIGNATURE --------- Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Celox Laboratories, Inc. November 4, 1997 By /s/ Milo R. Polovina Milo R. Polovina, Chairman -----END PRIVACY-ENHANCED MESSAGE-----